Ginsenoside Rg3 exerts anticancer effects in lung cancer through metabolite Histon H3

Huiyan Xiao1, Yongcong Zhang2, Banghui Zhang2

  • 1Department of Clean Operating, Quanzhou First Hospital Quanzhou 362002, Fujian, China.

Abstract

Insights

Ginsenoside Rg3 alters lung cancer cell metabolism, downregulating Lamin A/C and inhibiting histidine metabolism. This natural compound suppresses tumor progression by targeting key pathways, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Metabolomics
  • Pharmacology

Background:

  • Lung cancer is a leading cause of cancer death.
  • Aberrant metabolism plays a critical role in lung cancer development and progression.
  • Ginsenoside Rg3 is a natural compound with potential anti-cancer properties.

Purpose of the Study:

  • To investigate the effects of ginsenoside Rg3 on the metabolic profile of lung cancer cells.
  • To elucidate the underlying mechanisms by which ginsenoside Rg3 exerts its anti-cancer effects.

Main Methods:

  • A549 lung cancer cells were xenografted into nude mice.
  • Mice were treated with ginsenoside Rg3 or saline.
  • LC/MS-based metabolomics was employed to analyze serum and fecal samples.

Main Results:

  • Ginsenoside Rg3 significantly altered metabolite profiles in serum and fecal samples.
  • Treatment downregulated Lamin A/C and Histon H3, indicating inhibition of histidine metabolism.
  • Ginsenoside Rg3 and Lamin A knockdown suppressed histamine-induced proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).

Conclusions:

  • Ginsenoside Rg3 effectively modulates the metabolic landscape in lung cancer.
  • It suppresses lung cancer progression by downregulating Lamin A/C via the histidine metabolic pathway.
  • Ginsenoside Rg3 presents a promising therapeutic agent for lung cancer treatment.